These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12065567)

  • 1. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
    Schuchter LM; Hensley ML; Meropol NJ; Winer EP;
    J Clin Oncol; 2002 Jun; 20(12):2895-903. PubMed ID: 12065567
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
    Hensley ML; Schuchter LM; Lindley C; Meropol NJ; Cohen GI; Broder G; Gradishar WJ; Green DM; Langdon RJ; Mitchell RB; Negrin R; Szatrowski TP; Thigpen JT; Von Hoff D; Wasserman TH; Winer EP; Pfister DG
    J Clin Oncol; 1999 Oct; 17(10):3333-55. PubMed ID: 10506637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of cancer chemotherapy. Cytoprotective agents].
    Lopez M
    Clin Ter; 2001; 152(2):135-43. PubMed ID: 11441524
    [No Abstract]   [Full Text] [Related]  

  • 4. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
    J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352.
    Bleyer A; Alberts DS
    Med Pediatr Oncol; 2003 Jun; 40(6):413; author reply 414. PubMed ID: 12692822
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.
    Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML
    Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.
    Links M; Lewis C
    Drugs; 1999 Mar; 57(3):293-308. PubMed ID: 10193684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future development of amifostine as a radioprotectant.
    Werner-Wasik M
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):1-2. PubMed ID: 10348254
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the use of chemoprotectants in cancer chemotherapy.
    Lewis C
    Drug Saf; 1994 Sep; 11(3):153-62. PubMed ID: 7811398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotective agents used in the treatment of patients with cancer.
    Hogle WP
    Semin Oncol Nurs; 2007 Aug; 23(3):213-24. PubMed ID: 17693348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique.
    Hellmann K
    J Clin Oncol; 2000 May; 18(9):2004-6. PubMed ID: 10784645
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs.
    Miller RC; Murley JS; Grdina DJ
    Radiat Res; 2014 May; 181(5):464-70. PubMed ID: 24754562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amifostine as a supporting treatment during cancer therapy].
    Jantunen E; Puistola U
    Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives].
    Büntzel J; Bokemeyer C; Wagner W;
    Onkologie; 2001 Feb; 24(1):81-6. PubMed ID: 11441287
    [No Abstract]   [Full Text] [Related]  

  • 16. WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
    Souid AK; Fahey RC; Dubowy RL; Newton GL; Bernstein ML
    Cancer Chemother Pharmacol; 1999; 44(6):498-504. PubMed ID: 10550571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioprotectants: current status and new directions.
    Grdina DJ; Murley JS; Kataoka Y
    Oncology; 2002; 63 Suppl 2():2-10. PubMed ID: 12466639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current role of chemotherapy protectors in cancer treatment.
    Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A
    Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine.
    Viele C
    Clin J Oncol Nurs; 1999 Jul; 3(3):128, 131. PubMed ID: 10690046
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of cytoprotective agents in platinum anticancer therapy.
    Jakupec MA; Galanski M; Keppler BK
    Met Ions Biol Syst; 2004; 42():179-208. PubMed ID: 15206103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.